FDA Inspection 1035268 — Longood Medicine (Beijing) Co Ltd
The FDA completed an inspection of Longood Medicine (Beijing) Co Ltd on September 29, 2017 in Beijing. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 29, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beijing (China)